Pancreatic Cancer Research

Clinical trialObsUnknown

Pharmacotyping of Pancreatic Patient-derived Organoids

Pharmacotyping of Patient-derived Pancreatic Cancer Organoids From Endoscopic Ultrasound-guided Biopsy as a Tool for Predicting Oncological Response

NCT05196334↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Outcome unknown
Phase
Obs
Status
Unknown
Study type
Observational
Start
1 July 2021
Expected end
31 August 2025
Enrollment
88 participants
Sites
1
Primary outcomes
Measurement of organoid's response to therapy; Validation of patient's response to therapy; Comparison between organoid's and patient's response
Sponsor
Other
Results posted
No
Last update
3 October 2024

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 8